Skip to main content

Market Overview

Height Capital Markets Picks Winners, Losers From Congressional Opioid Legislation

Share:
Height Capital Markets Picks Winners, Losers From Congressional Opioid Legislation

Opioid legislation recently passed in the House of Representatives includes a temporary lift on the ban on Medicaid funding for substance use disorder and the definition of eligible institutions for mental disease facilities, according to Height Capital Markets

The Thesis

The bill will temporarily repeal the IMD exclusion and require Medicaid issuers to rebate payments exceeding an 85-percent medical loss ratio, creating a "material tailwind" for inpatient behavioral health providers like Acadia Healthcare (NASDAQ: ACHC) and a material headwind for managed care organizations levered to Medicaid like Centene Corp (NYSE: CNC), Molina Healthcare, Inc. (NYSE: MOH) and WellCare Health Plans, Inc. (NYSE: WCG), the Height analysts said. 

This legislation will likely proceed at an expedited rate, according to Height Capital Markets.

"We expect the Senate will send final opioids legislation to President Donald Trump's desk this week, following the House's passage of H.R. 6 on Friday, Sept. 28 by a vote of 393-8. Included in the final legislation are policies that represent tailwinds for behavioral health providers and headwinds for Medicaid managed care issuers.”

According to data from the National Institute on Drug Abuse, between 8 and 12 percent of patients develop an opioid use disorder, accounting for 115 daily opioid overdoses in the U.S, Height said. 

Price Action

Centene was trading 0.69 percent at $145.78 at the time of publication Monday, while WellCare experienced a rise of 0.31 percent for a $321.49. share price. Acadia Healthcare Co. (NASDAQ: ACHA) was up 0.82 percent at $20.93 at the time of publicatioon Monday, while Molina was down 0.22 percent at $148.41.

Related Links:

22 Stocks To Watch After President Trump Declares Opioid Epidemic A National Health Emergency

Analyst: Opioid Legislation Likely Stalled In Senate Until After November Elections

Latest Ratings for CNC

DateFirmActionFromTo
Mar 2021MizuhoInitiates Coverage OnNeutral
Jan 2021JefferiesDowngradesBuyHold
Dec 2020SVB LeerinkMaintainsOutperform

View More Analyst Ratings for CNC
View the Latest Analyst Ratings

 

Related Articles (CNC + WCG)

View Comments and Join the Discussion!

Posted-In: health care companies Height Capital Markets National Institute on Drug AbuseHealth Care Politics Analyst Ratings Media General

Latest Ratings

StockFirmActionPT
MTEMB of A SecuritiesInitiates Coverage On12.0
FCXUBSDowngrades36.0
UWMCBarclaysInitiates Coverage On10.0
ADMB of A SecuritiesInitiates Coverage On68.0
UNHArgus ResearchUpgrades450.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com